| Title | Reviews in Endocrine and Metabolic Disorders |
| Abbreviation | Rev. Endocr. Metab. Disord. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1) |
| h-index | 99 |
| Overall Rank/Ranking | 1286 |
| SCImago Journal Rank (SJR) | 2.075 |
| Impact Score | 7.32 |
| Publisher | Springer Netherlands |
| Country | Netherlands |
| ISSN | 15732606, 13899155 |
| Best Quartile | Q1 |
| Coverage History | 2000-2023 |
Reviews in Endocrine and Metabolic Disorders is an international journal dedicated to students, clinicians and researchers involved in the broad area of endocrinology and metabolism. This field of medicine and biology is rapidly advancing and a major challenge is to keep abreast of the advances in the field.
The mission of this review journal is to keep those interested individuals informed of all the latest exciting advancements that are essential to their research or clinical practice.
The format of this review journal differs from existing journals. Each of the quarterly issues covers a specific topic. Ten to twelve articles will be published by world leaders in this area.
Reviews in Endocrine and Metabolic Disorders is a journal covering the technologies/fields/categories related to Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1). It is published by Springer Netherlands. The overall rank of Reviews in Endocrine and Metabolic Disorders is 1286. According to SCImago Journal Rank (SJR), this journal is ranked 2.075. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 99. The best quartile for this journal is Q1.
The ISSN of Reviews in Endocrine and Metabolic Disorders journal is 15732606, 13899155. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Reviews in Endocrine and Metabolic Disorders is cited by a total of 1783 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Reviews in Endocrine and Metabolic Disorders is 7.32, which is computed in 2024 as per its definition. Reviews in Endocrine and Metabolic Disorders IF is decreased by a factor of 0.66 and approximate percentage change is -8.27% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Reviews in Endocrine and Metabolic Disorders is 7.32. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 7.32 |
| 2022 | 7.98 |
| 2021 | 8.69 |
| 2020 | 5.25 |
| 2019 | 6.21 |
| 2018 | 5.58 |
| 2017 | 4.84 |
| 2016 | 5.48 |
| 2015 | 5.56 |
| 2014 | 5.08 |
Reviews in Endocrine and Metabolic Disorders has an h-index of 99. It means 99 articles of this journal have more than 99 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Reviews in Endocrine and Metabolic Disorders is 15732606, 13899155. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Reviews in Endocrine and Metabolic Disorders is 1286. According to SCImago Journal Rank (SJR), this journal is ranked 2.075. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.075 |
| 2022 | 1.835 |
| 2021 | 1.780 |
| 2020 | 1.916 |
| 2019 | 1.641 |
| 2018 | 1.929 |
| 2017 | 2.089 |
| 2016 | 2.309 |
| 2015 | 2.353 |
| 2014 | 1.860 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1286 |
| 2022 | 1523 |
| 2021 | 1535 |
| 2020 | 1432 |
| 2019 | 1893 |
| 2018 | 1459 |
| 2017 | 1286 |
| 2016 | 1073 |
| 2015 | 1060 |
| 2014 | 1603 |
Reviews in Endocrine and Metabolic Disorders is published by Springer Netherlands. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2000-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Reviews in Endocrine and Metabolic Disorders is Rev. Endocr. Metab. Disord.. This abbreviation ('Rev. Endocr. Metab. Disord.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Reviews in Endocrine and Metabolic Disorders latest impact IF is 7.32. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 8.69 (2021) and 4.84 (2017), respectively, in the last 10 years. Moreover, its average IS is 6.2 in the previous 10 years.
The Reviews in Endocrine and Metabolic Disorders has an SJR (SCImago Journal Rank) of 2.075, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 2.353 in 2015 and the lowest being 1.641 in 2019. Furthermore, the average SJR of the Reviews in Endocrine and Metabolic Disorders over the previous 10-year period stands at 6.2.
The latest h-index of the Reviews in Endocrine and Metabolic Disorders is 99.
The Reviews in Endocrine and Metabolic Disorders is published by the Springer Netherlands, with its country of publication being the Netherlands.
The Reviews in Endocrine and Metabolic Disorders is currently ranked 1286 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1060 in 2015 and its lowest position of 1893 in 2019.
The standard ISO4 abbreviation for the Reviews in Endocrine and Metabolic Disorders is Rev. Endocr. Metab. Disord..
Reviews in Endocrine and Metabolic Disorders is classified as a journal that the Springer Netherlands publishes.
The Reviews in Endocrine and Metabolic Disorders encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Reviews in Endocrine and Metabolic Disorders is assigned the following International Standard Serial Numbers (ISSN): 15732606, 13899155.
The best quartile for the Reviews in Endocrine and Metabolic Disorders is Q1 (2023).
The Reviews in Endocrine and Metabolic Disorders coverage history can be summarized as follows: 2000-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Competition Law and Economics | journal | 10133 | Oxford University Press | 30 | 0.96 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| International Journal of Applied Linguistics | journal | 6241 | Wiley-Blackwell Publishing Ltd | 53 | 1.91 |
| British Journal of Special Education | journal | 16076 | Wiley-Blackwell Publishing Ltd | 44 | 0.78 |
| European Journal of Education | journal | 4662 | Wiley-Blackwell Publishing Ltd | 59 | 3.64 |
| Transnational Corporations | journal | 11181 | UNCTAD United Nations Conference on Trade and Development | 28 | 1.83 |
| Journal of Imaging Science and Technology | journal | 17857 | Society for Imaging Science and Technology | 45 | 0.68 |
| International Journal of Pest Management | journal | 13414 | Taylor and Francis Ltd. | 54 | 1.40 |
| HOMO- Journal of Comparative Human Biology | journal | 20265 | Elsevier B.V. | 38 | 0.79 |
| WSEAS Transactions on Environment and Development | journal | 20430 | World Scientific and Engineering Academy and Society | 25 | 0.92 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 7.32 |
| 2022 | 7.98 |
| 2021 | 8.69 |
| 2020 | 5.25 |
| 2019 | 6.21 |
| 2018 | 5.58 |
| 2017 | 4.84 |
| 2016 | 5.48 |
| 2015 | 5.56 |
| 2014 | 5.08 |
